TINN2 is a European research network (Collaborative Project) supported by the European Commission under the Health Cooperation Work Programme of the 7 th Framework Programme.

News & Events

 

TINN European Survey on the Use of Antibiotics in NICUs

The survey results are now available and the published article has been published.

Please click here to consult it.

 

MANY THANKS to all the Neonatal Intensive Care Units that dedicated their time to partipate in the TINN2 survey.

 

Consortium final meeting on 8th October 2015, in Paris, France

The official event of the TINN2 FP7 European Research Project was organised by Inserm-Transfert on 8th October 2015 in Paris (France).

This meeting gathered together all TINN2 partners for presenting and discussing the latest progresses within TINN2 activities, a project on preclinical studies and paediatric investigation plans for children, under the coordination of the French National Institute of Health and Medical Research (Inserm).

European Congress of Clinical Microbiology and Infectious Diseases, London, United Kingdom 31st to 4th April 2012

 

TINN2 Project was presented on Poster at the ECCMID congress in London, United Kingdom.

Brochure PDF :

University of Liverpool

The University of Liverpool is a large research-active University that receives €120 million/annum from a broad range of funding (EU, UK National Institute for Health Research, UK MRC, Wellcome Trust, Industry.

Liverpool Women’s Hospital is the largest single site maternity unit in the U.K. Our neonatal unit has 48 cots (18 Intensive Care Cots) with 1200 admissions each year: 240 <32 weeks gestation. During 2000–2005, we recruited 612 neonates to randomized controlled trials, 5,262 patients to short-term observational studies and collected data from 668 patients involved in long-term follow-up studies of neurodevelopmental outcome. We are beneficiaries in the EuroNeoNet (funded by EC FP6) and TINN (funded by EC FP7). The Royal Liverpool Children’s NHS Trust (Alder Hey Children’s Hospital) cares for more than 200,000 children every year. The Trust hosts the UK Medicines for Children Research Network (MCRN) Co-ordinating Centre and Clinical Trials Unit as well as a local research network. The Department of Pharmacy collaborates with several research groups to develop and test formulations of medicines for children. We have close links with the University Division of Medical Microbiology which is part of the U.K. National Biomedical Specialist Research Centre for Infection.

M. Turner: Lead for development of PIP for ciprofloxacin in neonates (WP3) in EC FP7-funded TINN project. Member: Executive of MCRN National Co-ordinating centre, U.K. Clinical Studies Group in Neonatology, Programme Management Group investigating “Adverse Drug Reactions in Children”, Project Management Group investigating “Manipulation of adult dosage forms for children and neonates” and Trial Management Group of 4 RCTs.

 

Back to the list of institutions